Call to Action: Respiratory virus infections and cardiovascular disease (CVD)
Vaccination against respiratory viruses can reduce the risk of complications associated with CVDs.
What do B- and T-cells do and how do they respond?
ESWI addresses common questions and misconceptions amongst the general public regarding influenza, COVID-19 and RSV. These responses, elaborated by ESWI Board Members and coalition partners, aim to increase public awareness and prevent misinformation.
What is the difference between innate and adaptive immune response?
ESWI addresses common questions and misconceptions amongst the general public regarding influenza, COVID-19 and RSV. These responses, elaborated by ESWI Board Members and coalition partners, aim to increase public awareness and prevent misinformation.
News
Policy & Recommendations
Joint Statement of the Steering Group on Influenza Vaccination on the Council Conclusions on the Future of the European Health Union: A Europe That Cares, Prepares, and Protects
The Steering Group strongly supports promotion of immunisation and prevention, whilst recognising the need for additional measures to address existing gaps and further enhance the effectiveness of these initiatives
Impact of twelve immunization-preventable infectious diseases on population health using disability-adjusted life years (DALYs) in Spain
The objective of this study is to estimate the burden of selected immunization-preventable infectious diseases in Spain.
Defining the balance between optimal immunity and immunopathology in influenza virus infection
Influenza A viruses remain a global threat to human health, with continued pandemic potential.
|
9th Influenza Conference 2023
Scientific highlights of the 9th ESWI Influenza Conference
With promising developments in the field of respiratory viral infections, the conference sessions covered hot topics on seasonal, pandemic, and zoonotic influenza viruses, as well as other respiratory viruses such as RSV and SARS-CoV-2.
Paving the way to life course immunisation in Europe podcast series
Dr Vytenis Andriukaitis, former European Commissioner and experienced health advocate, discusses with host Gary Finnegan the significance of advocating for vaccination throughout life.
Socio-Economic Value of Adult Immunisation Programmes report
Adult vaccines can return up to 19 times their initial investment to society, when their significant benefits beyond the healthcare system are monetised. This report has been conducted by the Office of Health Economics.
|
ESWI Respiratory Virus Summit 2024
ESWI Respiratory Virus Summit 2024 recap video
The discussions highlighted the crucial role of prevention, treatment and access to immunisation programmes to raise awareness and decrease the cases of RSV hospitalisations and deaths of young children and older adults.
